nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0209	0.0365	CcSEcCtD
Olopatadine—Laryngeal pain—Telbivudine—hepatitis B	0.0207	0.0362	CcSEcCtD
Olopatadine—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0183	0.032	CcSEcCtD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—FAS—hepatitis B	0.0152	0.0358	CbGpPWpGaD
Olopatadine—S100A2—p73 transcription factor network—FAS—hepatitis B	0.0112	0.0264	CbGpPWpGaD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—CDKN2A—hepatitis B	0.0102	0.0241	CbGpPWpGaD
Olopatadine—Upper respiratory tract infection—Entecavir—hepatitis B	0.01	0.0175	CcSEcCtD
Olopatadine—S100A12—DEx/H-box helicases activate type I IFN and inflammatory cytokines production—NFKB1—hepatitis B	0.0092	0.0217	CbGpPWpGaD
Olopatadine—Nasopharyngitis—Telbivudine—hepatitis B	0.00917	0.016	CcSEcCtD
Olopatadine—Influenza—Telbivudine—hepatitis B	0.00886	0.0155	CcSEcCtD
Olopatadine—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0088	0.0154	CcSEcCtD
Olopatadine—Oropharyngeal pain—Lamivudine—hepatitis B	0.00875	0.0153	CcSEcCtD
Olopatadine—S100B—DEx/H-box helicases activate type I IFN and inflammatory cytokines production—NFKB1—hepatitis B	0.0087	0.0205	CbGpPWpGaD
Olopatadine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00836	0.0146	CcSEcCtD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—CDKN1A—hepatitis B	0.00835	0.0197	CbGpPWpGaD
Olopatadine—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00824	0.0144	CcSEcCtD
Olopatadine—Immune system disorder—Entecavir—hepatitis B	0.0078	0.0136	CcSEcCtD
Olopatadine—Photophobia—Lamivudine—hepatitis B	0.00747	0.0131	CcSEcCtD
Olopatadine—Back pain—Adefovir Dipivoxil—hepatitis B	0.00709	0.0124	CcSEcCtD
Olopatadine—S100A2—Direct p53 effectors—FAS—hepatitis B	0.00709	0.0167	CbGpPWpGaD
Olopatadine—Hypoaesthesia—Telbivudine—hepatitis B	0.00706	0.0123	CcSEcCtD
Olopatadine—Pharyngitis—Telbivudine—hepatitis B	0.00704	0.0123	CcSEcCtD
Olopatadine—Cough—Adefovir Dipivoxil—hepatitis B	0.0064	0.0112	CcSEcCtD
Olopatadine—Mediastinal disorder—Telbivudine—hepatitis B	0.00639	0.0112	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00635	0.0111	CcSEcCtD
Olopatadine—S100A12—RIP-mediated NFkB activation via ZBP1—NFKB1—hepatitis B	0.00627	0.0148	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0062	0.0108	CcSEcCtD
Olopatadine—S100A2—p73 transcription factor network—CDKN1A—hepatitis B	0.00616	0.0145	CbGpPWpGaD
Olopatadine—Infection—Entecavir—hepatitis B	0.00609	0.0106	CcSEcCtD
Olopatadine—Thirst—Lamivudine—hepatitis B	0.00607	0.0106	CcSEcCtD
Olopatadine—Dysgeusia—Telbivudine—hepatitis B	0.00605	0.0106	CcSEcCtD
Olopatadine—Nervous system disorder—Entecavir—hepatitis B	0.00602	0.0105	CcSEcCtD
Olopatadine—Back pain—Telbivudine—hepatitis B	0.00597	0.0104	CcSEcCtD
Olopatadine—Skin disorder—Entecavir—hepatitis B	0.00596	0.0104	CcSEcCtD
Olopatadine—Muscle spasms—Telbivudine—hepatitis B	0.00594	0.0104	CcSEcCtD
Olopatadine—S100B—RIP-mediated NFkB activation via ZBP1—NFKB1—hepatitis B	0.00593	0.014	CbGpPWpGaD
Olopatadine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00587	0.0102	CcSEcCtD
Olopatadine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00581	0.0102	CcSEcCtD
Olopatadine—Ill-defined disorder—Telbivudine—hepatitis B	0.00573	0.01	CcSEcCtD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNB1—hepatitis B	0.00569	0.0134	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated NF-kB activation—NFKB1—hepatitis B	0.00563	0.0133	CbGpPWpGaD
Olopatadine—Malaise—Telbivudine—hepatitis B	0.00557	0.00972	CcSEcCtD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNA1—hepatitis B	0.00555	0.0131	CbGpPWpGaD
Olopatadine—Somnolence—Entecavir—hepatitis B	0.00545	0.00952	CcSEcCtD
Olopatadine—Cough—Telbivudine—hepatitis B	0.00539	0.00941	CcSEcCtD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNB1—hepatitis B	0.00538	0.0127	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated NF-kB activation—NFKB1—hepatitis B	0.00532	0.0126	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Entecavir—hepatitis B	0.0053	0.00925	CcSEcCtD
Olopatadine—Fatigue—Entecavir—hepatitis B	0.00529	0.00924	CcSEcCtD
Olopatadine—S100A12—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NFKB1—hepatitis B	0.00528	0.0125	CbGpPWpGaD
Olopatadine—S100A12—ZBP1(DAI) mediated induction of type I IFNs—NFKB1—hepatitis B	0.00528	0.0125	CbGpPWpGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNA1—hepatitis B	0.00525	0.0124	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00522	0.00912	CcSEcCtD
Olopatadine—Discomfort—Telbivudine—hepatitis B	0.00519	0.00907	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00517	0.00902	CcSEcCtD
Olopatadine—Nasopharyngitis—Lamivudine—hepatitis B	0.00517	0.00902	CcSEcCtD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNA2—hepatitis B	0.00517	0.0122	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—TLR2—hepatitis B	0.00504	0.0119	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Entecavir—hepatitis B	0.00502	0.00876	CcSEcCtD
Olopatadine—S100B—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NFKB1—hepatitis B	0.00499	0.0118	CbGpPWpGaD
Olopatadine—S100B—ZBP1(DAI) mediated induction of type I IFNs—NFKB1—hepatitis B	0.00499	0.0118	CbGpPWpGaD
Olopatadine—Influenza—Lamivudine—hepatitis B	0.00499	0.00872	CcSEcCtD
Olopatadine—Nervous system disorder—Telbivudine—hepatitis B	0.00494	0.00863	CcSEcCtD
Olopatadine—Skin disorder—Telbivudine—hepatitis B	0.00489	0.00855	CcSEcCtD
Olopatadine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00489	0.00855	CcSEcCtD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNA2—hepatitis B	0.00489	0.0115	CbGpPWpGaD
Olopatadine—Abdominal pain—Entecavir—hepatitis B	0.00485	0.00847	CcSEcCtD
Olopatadine—Body temperature increased—Entecavir—hepatitis B	0.00485	0.00847	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—TLR2—hepatitis B	0.00476	0.0112	CbGpPWpGaD
Olopatadine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00473	0.00826	CcSEcCtD
Olopatadine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00473	0.00826	CcSEcCtD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—CD14—hepatitis B	0.00454	0.0107	CbGpPWpGaD
Olopatadine—Depression—Lamivudine—hepatitis B	0.00444	0.00775	CcSEcCtD
Olopatadine—Asthenia—Entecavir—hepatitis B	0.0044	0.00769	CcSEcCtD
Olopatadine—S100A12—MyD88-independent cascade—CD14—hepatitis B	0.00436	0.0103	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00435	0.0076	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—TLR2—hepatitis B	0.00435	0.0103	CbGpPWpGaD
Olopatadine—Fatigue—Telbivudine—hepatitis B	0.00434	0.00759	CcSEcCtD
Olopatadine—Pain—Telbivudine—hepatitis B	0.00431	0.00753	CcSEcCtD
Olopatadine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00429	0.0075	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—CD14—hepatitis B	0.00429	0.0101	CbGpPWpGaD
Olopatadine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00423	0.00739	CcSEcCtD
Olopatadine—Epistaxis—Lamivudine—hepatitis B	0.0042	0.00733	CcSEcCtD
Olopatadine—Diarrhoea—Entecavir—hepatitis B	0.0042	0.00733	CcSEcCtD
Olopatadine—Sinusitis—Lamivudine—hepatitis B	0.00418	0.0073	CcSEcCtD
Olopatadine—Feeling abnormal—Telbivudine—hepatitis B	0.00415	0.00725	CcSEcCtD
Olopatadine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00412	0.0072	CcSEcCtD
Olopatadine—S100B—MyD88-independent cascade—CD14—hepatitis B	0.00412	0.00972	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—TLR2—hepatitis B	0.00411	0.0097	CbGpPWpGaD
Olopatadine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00409	0.00715	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—TLR2—hepatitis B	0.00409	0.00964	CbGpPWpGaD
Olopatadine—Dizziness—Entecavir—hepatitis B	0.00406	0.00708	CcSEcCtD
Olopatadine—Rhinitis—Lamivudine—hepatitis B	0.00401	0.007	CcSEcCtD
Olopatadine—Body temperature increased—Telbivudine—hepatitis B	0.00398	0.00696	CcSEcCtD
Olopatadine—Abdominal pain—Telbivudine—hepatitis B	0.00398	0.00696	CcSEcCtD
Olopatadine—Hypoaesthesia—Lamivudine—hepatitis B	0.00398	0.00695	CcSEcCtD
Olopatadine—Pharyngitis—Lamivudine—hepatitis B	0.00397	0.00693	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—CD14—hepatitis B	0.00392	0.00924	CbGpPWpGaD
Olopatadine—Vomiting—Entecavir—hepatitis B	0.0039	0.00681	CcSEcCtD
Olopatadine—S100A2—Direct p53 effectors—CDKN1A—hepatitis B	0.0039	0.00919	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—PTEN—hepatitis B	0.00389	0.00917	CbGpPWpGaD
Olopatadine—Rash—Entecavir—hepatitis B	0.00387	0.00675	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—TLR2—hepatitis B	0.00387	0.00912	CbGpPWpGaD
Olopatadine—Dermatitis—Entecavir—hepatitis B	0.00386	0.00675	CcSEcCtD
Olopatadine—Headache—Entecavir—hepatitis B	0.00384	0.00671	CcSEcCtD
Olopatadine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00381	0.00665	CcSEcCtD
Olopatadine—Rash—Adefovir Dipivoxil—hepatitis B	0.00377	0.00659	CcSEcCtD
Olopatadine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00377	0.00658	CcSEcCtD
Olopatadine—Headache—Adefovir Dipivoxil—hepatitis B	0.00375	0.00655	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—CD14—hepatitis B	0.00371	0.00874	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—CD14—hepatitis B	0.00369	0.00869	CbGpPWpGaD
Olopatadine—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00365	0.0086	CbGpPWpGaD
Olopatadine—Nausea—Entecavir—hepatitis B	0.00364	0.00636	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—TLR2—hepatitis B	0.00364	0.00859	CbGpPWpGaD
Olopatadine—Asthenia—Telbivudine—hepatitis B	0.00362	0.00631	CcSEcCtD
Olopatadine—Immune system disorder—Lamivudine—hepatitis B	0.00361	0.00631	CcSEcCtD
Olopatadine—Mediastinal disorder—Lamivudine—hepatitis B	0.0036	0.00629	CcSEcCtD
Olopatadine—Pruritus—Telbivudine—hepatitis B	0.00357	0.00623	CcSEcCtD
Olopatadine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00355	0.00621	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—CD14—hepatitis B	0.00349	0.00822	CbGpPWpGaD
Olopatadine—Erythema—Lamivudine—hepatitis B	0.00348	0.00608	CcSEcCtD
Olopatadine—Diarrhoea—Telbivudine—hepatitis B	0.00345	0.00602	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—TLR2—hepatitis B	0.00344	0.00812	CbGpPWpGaD
Olopatadine—Dysgeusia—Lamivudine—hepatitis B	0.00341	0.00595	CcSEcCtD
Olopatadine—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00339	0.00799	CbGpPWpGaD
Olopatadine—Back pain—Lamivudine—hepatitis B	0.00337	0.00588	CcSEcCtD
Olopatadine—Muscle spasms—Lamivudine—hepatitis B	0.00335	0.00584	CcSEcCtD
Olopatadine—Dizziness—Telbivudine—hepatitis B	0.00333	0.00582	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—CD14—hepatitis B	0.00328	0.00774	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Lamivudine—hepatitis B	0.00323	0.00564	CcSEcCtD
Olopatadine—Vomiting—Telbivudine—hepatitis B	0.0032	0.0056	CcSEcCtD
Olopatadine—Rash—Telbivudine—hepatitis B	0.00318	0.00555	CcSEcCtD
Olopatadine—Dermatitis—Telbivudine—hepatitis B	0.00317	0.00554	CcSEcCtD
Olopatadine—Headache—Telbivudine—hepatitis B	0.00316	0.00551	CcSEcCtD
Olopatadine—Malaise—Lamivudine—hepatitis B	0.00314	0.00548	CcSEcCtD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—TLR4—hepatitis B	0.00311	0.00734	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—CD14—hepatitis B	0.0031	0.00732	CbGpPWpGaD
Olopatadine—Cough—Lamivudine—hepatitis B	0.00304	0.0053	CcSEcCtD
Olopatadine—Nausea—Telbivudine—hepatitis B	0.00299	0.00523	CcSEcCtD
Olopatadine—S100A12—MyD88-independent cascade—TLR4—hepatitis B	0.00299	0.00704	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—TLR4—hepatitis B	0.00294	0.00694	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00294	0.00514	CcSEcCtD
Olopatadine—Discomfort—Lamivudine—hepatitis B	0.00293	0.00511	CcSEcCtD
Olopatadine—Dry mouth—Lamivudine—hepatitis B	0.0029	0.00506	CcSEcCtD
Olopatadine—Oedema—Lamivudine—hepatitis B	0.00284	0.00496	CcSEcCtD
Olopatadine—S100B—MyD88-independent cascade—TLR4—hepatitis B	0.00282	0.00666	CbGpPWpGaD
Olopatadine—Infection—Lamivudine—hepatitis B	0.00282	0.00493	CcSEcCtD
Olopatadine—Nervous system disorder—Lamivudine—hepatitis B	0.00278	0.00486	CcSEcCtD
Olopatadine—Skin disorder—Lamivudine—hepatitis B	0.00276	0.00482	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—TLR4—hepatitis B	0.00269	0.00633	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—TP53—hepatitis B	0.00265	0.00626	CbGpPWpGaD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—CTNNB1—hepatitis B	0.00258	0.00609	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—TLR4—hepatitis B	0.00254	0.00599	CbGpPWpGaD
Olopatadine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00253	0.00598	CbGpPWpGaD
Olopatadine—Dyspnoea—Lamivudine—hepatitis B	0.00253	0.00442	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—TLR4—hepatitis B	0.00253	0.00596	CbGpPWpGaD
Olopatadine—Somnolence—Lamivudine—hepatitis B	0.00252	0.00441	CcSEcCtD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—NFKB1—hepatitis B	0.00251	0.00591	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00245	0.00428	CcSEcCtD
Olopatadine—Fatigue—Lamivudine—hepatitis B	0.00245	0.00428	CcSEcCtD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—CTNNB1—hepatitis B	0.00244	0.00576	CbGpPWpGaD
Olopatadine—Pain—Lamivudine—hepatitis B	0.00243	0.00424	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—TLR4—hepatitis B	0.00239	0.00563	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—NFKB1—hepatitis B	0.00237	0.00559	CbGpPWpGaD
Olopatadine—Feeling abnormal—Lamivudine—hepatitis B	0.00234	0.00409	CcSEcCtD
Olopatadine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00232	0.00406	CcSEcCtD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—hepatitis B	0.00226	0.00534	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—TLR4—hepatitis B	0.00225	0.00531	CbGpPWpGaD
Olopatadine—Abdominal pain—Lamivudine—hepatitis B	0.00224	0.00392	CcSEcCtD
Olopatadine—Body temperature increased—Lamivudine—hepatitis B	0.00224	0.00392	CcSEcCtD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—NFKB1—hepatitis B	0.00215	0.00507	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—hepatitis B	0.00214	0.00505	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—TLR4—hepatitis B	0.00213	0.00502	CbGpPWpGaD
Olopatadine—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00212	0.005	CbGpPWpGaD
Olopatadine—Hypersensitivity—Lamivudine—hepatitis B	0.00209	0.00365	CcSEcCtD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—NFKB1—hepatitis B	0.00205	0.00483	CbGpPWpGaD
Olopatadine—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00204	0.00481	CbGpPWpGaD
Olopatadine—Asthenia—Lamivudine—hepatitis B	0.00204	0.00356	CcSEcCtD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—NFKB1—hepatitis B	0.00203	0.00479	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—hepatitis B	0.00203	0.00478	CbGpPWpGaD
Olopatadine—Pruritus—Lamivudine—hepatitis B	0.00201	0.00351	CcSEcCtD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—NFKB1—hepatitis B	0.00199	0.0047	CbGpPWpGaD
Olopatadine—Diarrhoea—Lamivudine—hepatitis B	0.00194	0.00339	CcSEcCtD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—NFKB1—hepatitis B	0.00194	0.00457	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—hepatitis B	0.00192	0.00453	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—hepatitis B	0.00192	0.00452	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—NFKB1—hepatitis B	0.00189	0.00446	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—NFKB1—hepatitis B	0.00188	0.00444	CbGpPWpGaD
Olopatadine—Dizziness—Lamivudine—hepatitis B	0.00188	0.00328	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—hepatitis B	0.00182	0.00429	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—NFKB1—hepatitis B	0.00181	0.00427	CbGpPWpGaD
Olopatadine—Vomiting—Lamivudine—hepatitis B	0.00181	0.00315	CcSEcCtD
Olopatadine—Rash—Lamivudine—hepatitis B	0.00179	0.00313	CcSEcCtD
Olopatadine—Dermatitis—Lamivudine—hepatitis B	0.00179	0.00312	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—NFKB1—hepatitis B	0.00179	0.00421	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNAR2—hepatitis B	0.00178	0.0042	CbGpPWpGaD
Olopatadine—Headache—Lamivudine—hepatitis B	0.00178	0.00311	CcSEcCtD
Olopatadine—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00172	0.00407	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—NFKB1—hepatitis B	0.00171	0.00404	CbGpPWpGaD
Olopatadine—Nausea—Lamivudine—hepatitis B	0.00169	0.00295	CcSEcCtD
Olopatadine—S100B—Immune System—IFNAR2—hepatitis B	0.00168	0.00397	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—NFKB1—hepatitis B	0.00163	0.00385	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DPA1—hepatitis B	0.00156	0.00367	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—NFKB1—hepatitis B	0.00154	0.00364	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—hepatitis B	0.00153	0.00362	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD274—hepatitis B	0.00147	0.00348	CbGpPWpGaD
Olopatadine—S100A12—Immune System—UBE2L3—hepatitis B	0.00147	0.00348	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DPA1—hepatitis B	0.00147	0.00347	CbGpPWpGaD
Olopatadine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00146	0.00343	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—hepatitis B	0.00145	0.00342	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—hepatitis B	0.00142	0.00335	CbGpPWpGaD
Olopatadine—S100B—Immune System—UBE2L3—hepatitis B	0.00139	0.00329	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD274—hepatitis B	0.00139	0.00329	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—NFKB1—hepatitis B	0.00137	0.00322	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PDCD1—hepatitis B	0.00135	0.00318	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—hepatitis B	0.00134	0.00317	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—NFKB1—hepatitis B	0.00129	0.00305	CbGpPWpGaD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—IL6—hepatitis B	0.00129	0.00303	CbGpPWpGaD
Olopatadine—S100B—Immune System—PDCD1—hepatitis B	0.00128	0.00301	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—hepatitis B	0.00127	0.003	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNGR1—hepatitis B	0.00125	0.00296	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—IL6—hepatitis B	0.00125	0.00295	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—CDKN1A—hepatitis B	0.00122	0.00289	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—PTEN—hepatitis B	0.00122	0.00288	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—IL6—hepatitis B	0.00122	0.00287	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—IL6—hepatitis B	0.00121	0.00285	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—hepatitis B	0.0012	0.00284	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNGR1—hepatitis B	0.00119	0.0028	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—IL6—hepatitis B	0.00119	0.0028	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—IL6—hepatitis B	0.00118	0.00279	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TLR2—hepatitis B	0.00118	0.00278	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IFNB1—hepatitis B	0.00117	0.00276	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IFNA1—hepatitis B	0.00114	0.00269	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—IL6—hepatitis B	0.00114	0.00269	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—IL6—hepatitis B	0.00114	0.00268	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—IL6—hepatitis B	0.00112	0.00264	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TLR2—hepatitis B	0.00112	0.00263	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IFNB1—hepatitis B	0.00111	0.00261	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IFNA1—hepatitis B	0.00108	0.00255	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MX1—hepatitis B	0.00108	0.00254	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—IL6—hepatitis B	0.00108	0.00254	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD14—hepatitis B	0.00106	0.00251	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IFNA2—hepatitis B	0.00106	0.00251	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—IL6—hepatitis B	0.00102	0.00241	CbGpPWpGaD
Olopatadine—S100B—Immune System—MX1—hepatitis B	0.00102	0.0024	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD14—hepatitis B	0.00101	0.00237	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IFNA2—hepatitis B	0.00101	0.00237	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—IL6—hepatitis B	0.000968	0.00228	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	0.000963	0.00227	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RIT2—hepatitis B	0.000951	0.00224	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SAG—hepatitis B	0.000951	0.00224	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	0.00091	0.00215	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00088	0.00208	CbGpPWpGaD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000869	0.00205	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—IL6—hepatitis B	0.000857	0.00202	CbGpPWpGaD
Olopatadine—Acepromazine—ALB—hepatitis B	0.000843	0.251	CrCbGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—hepatitis B	0.000811	0.00191	CbGpPWpGaD
Olopatadine—Thiothixene—ALB—hepatitis B	0.00081	0.242	CrCbGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—NFKB1—hepatitis B	0.000777	0.00183	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—IL6—hepatitis B	0.000763	0.0018	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HSPA5—hepatitis B	0.000756	0.00178	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TLR4—hepatitis B	0.000729	0.00172	CbGpPWpGaD
Olopatadine—S100B—Immune System—HSPA5—hepatitis B	0.000715	0.00169	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DPB1—hepatitis B	0.000714	0.00168	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000714	0.00168	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TLR4—hepatitis B	0.000689	0.00163	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TLR2—hepatitis B	0.000687	0.00162	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNB1—hepatitis B	0.000682	0.00161	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DPB1—hepatitis B	0.000675	0.00159	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNA1—hepatitis B	0.000665	0.00157	CbGpPWpGaD
Olopatadine—S100B—Immune System—TLR2—hepatitis B	0.00065	0.00153	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNB1—hepatitis B	0.000645	0.00152	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000644	0.00152	CbGpPWpGaD
Olopatadine—Clomipramine—ALB—hepatitis B	0.00064	0.191	CrCbGaD
Olopatadine—S100B—Immune System—IFNA1—hepatitis B	0.000629	0.00148	CbGpPWpGaD
Olopatadine—Nortriptyline—ALB—hepatitis B	0.000626	0.187	CrCbGaD
Olopatadine—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000626	0.00148	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD14—hepatitis B	0.000619	0.00146	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNA2—hepatitis B	0.000619	0.00146	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD14—hepatitis B	0.000586	0.00138	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNA2—hepatitis B	0.000586	0.00138	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL18—hepatitis B	0.000529	0.00125	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD40LG—hepatitis B	0.000527	0.00124	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD8A—hepatitis B	0.000521	0.00123	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD4—hepatitis B	0.000513	0.00121	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL18—hepatitis B	0.0005	0.00118	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD40LG—hepatitis B	0.000498	0.00117	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD8A—hepatitis B	0.000492	0.00116	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD4—hepatitis B	0.000486	0.00115	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-A—hepatitis B	0.000464	0.00109	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—F2—hepatitis B	0.000456	0.00108	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CTNNB1—hepatitis B	0.000456	0.00108	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000454	0.00107	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CDKN1A—hepatitis B	0.000446	0.00105	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PTEN—hepatitis B	0.000445	0.00105	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—NFKB1—hepatitis B	0.000442	0.00104	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-A—hepatitis B	0.000439	0.00104	CbGpPWpGaD
Olopatadine—Amitriptyline—ALB—hepatitis B	0.000434	0.13	CrCbGaD
Olopatadine—S100B—Innate Immune System—CTNNB1—hepatitis B	0.000431	0.00102	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TLR4—hepatitis B	0.000424	0.001	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DRB1—hepatitis B	0.000424	0.001	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CDKN1A—hepatitis B	0.000421	0.000994	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PTEN—hepatitis B	0.00042	0.000991	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—NFKB1—hepatitis B	0.000418	0.000987	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000411	0.00097	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000408	0.000963	CbGpPWpGaD
Olopatadine—S100B—Immune System—TLR4—hepatitis B	0.000401	0.000947	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DRB1—hepatitis B	0.000401	0.000946	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000379	0.000894	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL10—hepatitis B	0.000375	0.000885	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000352	0.000831	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL10—hepatitis B	0.000346	0.000816	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNG—hepatitis B	0.00031	0.00073	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000302	0.000713	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD4—hepatitis B	0.000299	0.000705	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000296	0.000698	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNG—hepatitis B	0.000293	0.000691	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR5—hepatitis B	0.000291	0.000687	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD4—hepatitis B	0.000283	0.000667	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—hepatitis B	0.000278	0.000655	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—hepatitis B	0.000275	0.000649	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR5—hepatitis B	0.000268	0.000633	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTNNB1—hepatitis B	0.000266	0.000626	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SAG—hepatitis B	0.000266	0.000626	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RIT2—hepatitis B	0.000266	0.000626	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—hepatitis B	0.000263	0.000619	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—hepatitis B	0.00026	0.000614	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDKN1A—hepatitis B	0.00026	0.000612	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PTEN—hepatitis B	0.000259	0.000611	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NFKB1—hepatitis B	0.000258	0.000608	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTNNB1—hepatitis B	0.000251	0.000592	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—F2—hepatitis B	0.00025	0.000589	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDKN1A—hepatitis B	0.000245	0.000579	CbGpPWpGaD
Olopatadine—S100B—Immune System—PTEN—hepatitis B	0.000245	0.000577	CbGpPWpGaD
Olopatadine—S100B—Immune System—NFKB1—hepatitis B	0.000244	0.000575	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—F2—hepatitis B	0.00023	0.000543	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL10—hepatitis B	0.000195	0.000461	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL10—hepatitis B	0.000178	0.000419	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—hepatitis B	0.000168	0.000397	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CTNNB1—hepatitis B	0.000162	0.000383	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—hepatitis B	0.000162	0.000381	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000162	0.000381	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN1A—hepatitis B	0.000159	0.000374	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTEN—hepatitis B	0.000158	0.000373	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NFKB1—hepatitis B	0.000158	0.000372	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—hepatitis B	0.000153	0.000361	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR5—hepatitis B	0.000152	0.000358	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR5—hepatitis B	0.000138	0.000325	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—hepatitis B	0.000131	0.000309	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—F2—hepatitis B	0.00013	0.000307	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—F2—hepatitis B	0.000118	0.000279	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKR1B1—hepatitis B	0.000112	0.000263	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—hepatitis B	0.000108	0.000255	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GGT2—hepatitis B	0.000107	0.000252	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL10—hepatitis B	0.000105	0.000247	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—hepatitis B	9.89e-05	0.000233	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—hepatitis B	8.76e-05	0.000207	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR5—hepatitis B	8.13e-05	0.000192	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—hepatitis B	7.95e-05	0.000188	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—F2—hepatitis B	6.98e-05	0.000165	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2A6—hepatitis B	6.48e-05	0.000153	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT2—hepatitis B	5.86e-05	0.000138	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT1—hepatitis B	5.06e-05	0.000119	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GGT1—hepatitis B	5.06e-05	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—hepatitis B	4.7e-05	0.000111	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—hepatitis B	4.68e-05	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CTNNB1—hepatitis B	4.54e-05	0.000107	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN1A—hepatitis B	4.43e-05	0.000104	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTEN—hepatitis B	4.42e-05	0.000104	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NFKB1—hepatitis B	4.4e-05	0.000104	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—hepatitis B	3.67e-05	8.64e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—hepatitis B	3.02e-05	7.12e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—hepatitis B	2.76e-05	6.51e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—hepatitis B	2.69e-05	6.35e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTEN—hepatitis B	2.05e-05	4.84e-05	CbGpPWpGaD
